In Silico Prioritization for Endocrine Active Substances (EAS) and Their in Vitro Validation

Toxicology Letters - Netherlands
doi 10.1016/j.toxlet.2016.06.1486
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV